Chiara Bellia

Summary

Affiliation: University of Palermo
Country: Italy

Publications

  1. ncbi Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity
    Antonino Tuttolomondo
    Dipartimento Biomedico di Medicina Interna e Specialistica Università degli Studi di Palermo, Italy
    Cardiovasc Diabetol 9:50. 2010
  2. ncbi Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction
    Marcello Ciaccio
    Department of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo, Palermo, Italy
    Curr Clin Pharmacol 5:30-6. 2010
  3. ncbi Aminoacid profile and oxidative status in children affected by Down syndrome before and after supplementary nutritional treatment
    Marcello Ciaccio
    Cattedra di Biochimica Clinica, Facolta di Medicina e Chirurgia, Sezione di Biochimica Medica, Dipartimento di Biotecnologie Mediche e Medicina Legale, Universita degli Studi di Palermo, Palermo, Italy
    Ital J Biochem 52:72-9. 2003
  4. ncbi Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): effect of a single session haemodialysis
    Marcello Ciaccio
    Clinical Biochemistry, Faculty of Medicine, University of Palermo, Palermo, Italy
    Clin Chem Lab Med 46:212-4. 2008
  5. ncbi Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections
    Marcello Ciaccio
    Chair of Clinical Biochemistry, Faculty of Medicine, University of Palermo, 90127 Palermo, Italy
    Clin Chim Acta 340:149-52. 2004
  6. ncbi The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins
    Sergio Siragusa
    Thrombosis/Haemostasis and Haematology Unit, University Hospital of Palermo, Italy
    Thromb Res 121:51-3. 2007
  7. ncbi C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients
    Nicoletta Vivona
    Department of Clinical Medicine and Emerging Diseases, Via del Vespro 141, Palermo, Italy
    Clin Biochem 42:1713-8. 2009
  8. ncbi Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
    Marcello Ciaccio
    Department of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo Italy
    Ther Clin Risk Manag 4:219-24. 2008
  9. ncbi Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease
    Chiara Bellia
    Department of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo Italy
    Ther Clin Risk Manag 3:999-1001. 2007
  10. ncbi Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus
    Ligia J Dominguez
    Geriatric Unit, Department of Clinical Medicine and Emerging Pathologies, University of Palermo, Palermo, Italy
    J Am Coll Nutr 29:1-6. 2010

Collaborators

  • Sergio Siragusa
  • A Pinto
  • A Tuttolomondo
  • Marcello Ciaccio
  • Giulia Bivona
  • Ligia J Dominguez
  • Nicoletta Vivona
  • Lavinia Vocca
  • Mario Barbagallo
  • Antonio Galioto
  • Giuseppe Costanza
  • Anna Ferlisi
  • Antonella Pineo
  • Ernesto Putignano
  • Mario Belvedere
  • Maurizio R Averna
  • Bruna Lo Sasso
  • Angelo Falletta
  • Angelo B Cefalù
  • Davide Noto
  • Gaia Chiarello
  • Riccardo Di Sciacca
  • Rossella Iatrino
  • Epifanio Di Natale
  • Maurizio Li Vecchi
  • Lucina Titone
  • Maria Di Gangi
  • Gabriella Fugardi
  • Francesco Scarlata
  • Amelia Romano
  • Salvatore Giordano
  • Maria Piccione
  • Mario Giuffrè
  • Antonino Bono
  • Giovanni Corsello
  • Vincenzo Macaione

Detail Information

Publications10

  1. ncbi Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity
    Antonino Tuttolomondo
    Dipartimento Biomedico di Medicina Interna e Specialistica Università degli Studi di Palermo, Italy
    Cardiovasc Diabetol 9:50. 2010
    ..On this basis the aim of our study was to evaluate plasma levels of adiponectin, resistin and IL-6 in subjects with diabetic foot in comparison with subjects without foot complications...
  2. ncbi Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction
    Marcello Ciaccio
    Department of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo, Palermo, Italy
    Curr Clin Pharmacol 5:30-6. 2010
    ..In conclusion, it is still unclear whether decreasing plasma levels of homocysteine through diet or drugs may be paralleled by a reduction in cardiovascular risk...
  3. ncbi Aminoacid profile and oxidative status in children affected by Down syndrome before and after supplementary nutritional treatment
    Marcello Ciaccio
    Cattedra di Biochimica Clinica, Facolta di Medicina e Chirurgia, Sezione di Biochimica Medica, Dipartimento di Biotecnologie Mediche e Medicina Legale, Universita degli Studi di Palermo, Palermo, Italy
    Ital J Biochem 52:72-9. 2003
    ....
  4. ncbi Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): effect of a single session haemodialysis
    Marcello Ciaccio
    Clinical Biochemistry, Faculty of Medicine, University of Palermo, Palermo, Italy
    Clin Chem Lab Med 46:212-4. 2008
    ....
  5. ncbi Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections
    Marcello Ciaccio
    Chair of Clinical Biochemistry, Faculty of Medicine, University of Palermo, 90127 Palermo, Italy
    Clin Chim Acta 340:149-52. 2004
    ..Furthermore, in patients with leukaemia in chemotherapy recovery, infections often induce relapses. The aim of the present study is to detect PCT levels in plasma in oncohaematologic patients with and without infections...
  6. ncbi The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins
    Sergio Siragusa
    Thrombosis/Haemostasis and Haematology Unit, University Hospital of Palermo, Italy
    Thromb Res 121:51-3. 2007
  7. ncbi C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients
    Nicoletta Vivona
    Department of Clinical Medicine and Emerging Diseases, Via del Vespro 141, Palermo, Italy
    Clin Biochem 42:1713-8. 2009
    ..The aim of this study was to evaluate the association between common atherosclerotic risk factors and markers of inflammation...
  8. ncbi Therapeutical approach to plasma homocysteine and cardiovascular risk reduction
    Marcello Ciaccio
    Department of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo Italy
    Ther Clin Risk Manag 4:219-24. 2008
    ....
  9. ncbi Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease
    Chiara Bellia
    Department of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo Italy
    Ther Clin Risk Manag 3:999-1001. 2007
    ..This is an observational study undertaken in aim to evaluate the association between metabolic syndrome (MS) and high homocysteinemia (HHcy) in relation with cardiovascular disease (CVD)...
  10. ncbi Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus
    Ligia J Dominguez
    Geriatric Unit, Department of Clinical Medicine and Emerging Pathologies, University of Palermo, Palermo, Italy
    J Am Coll Nutr 29:1-6. 2010
    ..We evaluated these parameters in relation to age and the presence of hypertension and type 2 diabetes mellitus...